Pneumococcal Vaccine Offers Protection To HIV-infected African Adults In Clinical Trial

A clinical trial of a vaccine against a major cause of pneumonia and meningitis has shown that it can prevent three out of four cases of re-infection in HIV-infected adults in Africa. The trials, conducted in Malawi and funded by the Wellcome Trust, studied the efficacy of a vaccine against infection with the Streptococcus pneumoniae bacteria...

Add to: del.icio.us | Digg